Cardiograft®

Video: Cardiovascular Facility Tour

Bio-Implants for Cardiac Procedures

Aortic Heart Valve

Aortic Heart Valve
Download a PDF

Cryopreserved     Description     Sizing
HVASAortic Heart ValveD = 16 mm and less
HVAMAortic Heart ValveD = 17 - 21 mm
HVALAortic Heart ValveD = 22 mm and greater
Freeze-dried     Description     Sizing
OCELL100

Clinical Application

  • Left side/aortic reconstructions
  • Aortic stenosis/atresia
  • Hypoplastic left heart
  • Repair of RVOTs (Right Ventricular Outflow Tract)

Features and Benefits

  • No anticoagulation therapy required
  • Exceptionally good hemodynamic performance
  • No immunosuppressive therapy needed
  • Non-thrombogenic
  • Non-hemolytic
  • Human tissue - most closely resembles native tissue
  • High resistance to infection

Ascending Aorta (non-valved)

Ascending Aorta (non-valved)
Download a PDF

Cryopreserved     Description     Sizing
AASAscending Aorta (non-valved)D = 16 mm and less
AAMAscending Aorta (non-valved)D = 17 - 21 mm
AALAscending Aorta (non-valved)D = 22 mm and greater

Clinical Application

  • Conduit repair

Features and Benefits

  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
  • No anticoagulation therapy required

Hemi-Pulmonary Artery

Hemi-Pulmonary Artery
Download a PDF

Cryopreserved     Description     Sizing
RHPARight Hemi-Pulmonary ArteryVaries
LHPALeft Hemi-Pulmonary ArteryVaries

Clinical Application

  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus 
  • Transposition of great vessels 
  • Hypoplastic left heart (modified Fontan)
  • Aortic stenosis/atresia
     

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection

Mono Cusp Patch

Mono Cusp Patch
Download a PDF

Cryopreserved     Description     Sizing
RMCPRight Mono Cusp PatchW/L Varies
LMCPLeft Mono Cusp PatchW/L Varies
MCPMono Cusp Patch1.0 cm or greater of conduit to the distal commissure

Clinical Application

  • Tetralogy of Fallot
  • RVOT/root enlargement procedures

Features and Benefits

  • Single valved section of main pulmonary trunk
  • Original annulus diameter
  • Length and width measured in centimeters
  • No minimum or maximum width

 

Pulmonary Artery (non-valved)

Pulmonary Artery (non-valved)
Download a PDF

Cryopreserved     Description     Sizing
PASPulmonary Artery (non-valved)D = 16 mm and less
PAMPulmonary Artery (non-valved)D = 17 - 21 mm
PALPulmonary Artery (non-valved)D = 22 mm and greater

Clinical Application

  • Right side/pulmonary reconstructions
  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus
  • Pulmonary root stenosis

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection

Pulmonary Heart Valve

Pulmonary Heart Valve
Download a PDF

Cryopreserved     Description     Sizing
HVPSPulmonary Heart ValveD = 16 mm and less
HVPMPulmonary Heart ValveD = 17 - 21 mm
HVPLPulmonary Heart ValveD = 22 mm and greater

Clinical Application

  • Right side/pulmonary reconstructions
  • Hypoplastic left heart (modified Fontan)
  • Ross procedure
  • Truncus arteriosus
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Pulmonary root stenosis

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection

Thoracic Aorta

Thoracic Aorta
Download a PDF

Cryopreserved     Description     Sizing
TASThoracic AortaD = 16 mm and less
TAMThoracic AortaD = 17 – 21 mm
TALThoracic AortaD = 22 mm and greater

Clinical Application

  • Infected descending aorta  
  • Conduit repair
  • Extra-cardiac shunt
     

Features and Benefits

  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection

Pulmonary Patch

Pulmonary Patch
Download a PDF

Description

Pulmonary patch section produced from the main pulmonary artery.

Cryopreserved     Description     Sizing
PPGNThin Pulmonary PatchW = 2 - 5 cm L=3 - 8 cm
PPGKThick Pulmonary PatchW = 2 - 5 cm L=3 - 8 cm

Clinical Application

  • Right side/pulmonary reconstructions
  • Tralogy of Fallot
  • Single ventricle/double outlet (Fontan)
  • Truncus arterious; ASD/VSD repair

 

Features and Benefits

  • No anticoagulation therapy required
  • Non-thromogenic
  • Non-hemolytic
  • No immunosuppressive therapy requiredHuman tissue - most closely resembles native tissue
  • High resistance to infection

Decellularized Pulmonary Patch

Decellularized Pulmonary Patch
Download a PDF

Description

Decellularized pulmonary patch with Matracell™.

Cryopreserved     Description     Sizing
DPPGNThin Pulmonary Patch (decellularized)W = 2 - 5 cm L=3 - 8 cm
DPPGKThick Pulmonary Patch (decellularized)W = 2 - 5 cm L=3 - 8 cm

Features and Benefits

Matracell™ safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant.

Decellularized Hemi-Pulmonary Artery

Decellularized Hemi-Pulmonary Artery
Download a PDF

Description

Decellularized Hemi-Pulmonary Artery with Matracell™

Frozen     Description     Sizing
DRHPARight Hemi-Pulmonary Artery (decellularized)Right
DLHPALeft Hemi-Pulmonary Artery (decellularized)Left


6,404 Lives Saved 1,947,146 Lives Healed